rs786205153
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP2PP3
The ENST00000378623.6(LRP4):c.3697G>A(p.Glu1233Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000205 in 1,461,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1233A) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000378623.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRP4 | NM_002334.4 | c.3697G>A | p.Glu1233Lys | missense_variant, splice_region_variant | 26/38 | ENST00000378623.6 | NP_002325.2 | |
LRP4 | XM_017017734.2 | c.3697G>A | p.Glu1233Lys | missense_variant, splice_region_variant | 26/39 | XP_016873223.1 | ||
LRP4 | XM_011520103.3 | c.2893G>A | p.Glu965Lys | missense_variant, splice_region_variant | 20/32 | XP_011518405.1 | ||
LRP4 | XM_011520104.3 | c.1462G>A | p.Glu488Lys | missense_variant, splice_region_variant | 11/23 | XP_011518406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRP4 | ENST00000378623.6 | c.3697G>A | p.Glu1233Lys | missense_variant, splice_region_variant | 26/38 | 1 | NM_002334.4 | ENSP00000367888 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461868Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 727240
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 17 Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | Apr 14, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2014 | - - |
Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 11, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this variant affects LRP4 protein function (PMID: 24234652). This variant has been observed in individual(s) with congenital myasthenic syndrome (PMID: 24234652). ClinVar contains an entry for this variant (Variation ID: 189820). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 1233 of the LRP4 protein (p.Glu1233Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at